✦ LIBER ✦

Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment

✍ Scribed by F. Vázquez-López; J.A. Manjón-Haces; R. Pérez-Alvarez; N. Pérez-Oliva

Book ID: 108667532
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 59 KB
Volume: 150
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2004.05957.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eczema-like lesions and disruption of th

Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment: reply from authors

✍ J. Lübbe; F. Negro; K. Bullani-Kerl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Diffuse inflammatory lesions in patients

Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients

✍ O. Dereure; N. Raison-Peyron; D. Larrey; F. Blanc; J-J. Guilhou 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Background: Cutaneous side-effects of treatment with interferon alfa or interferon alfa plus ribavirin in patients with hepatitis c have already been reported but they are mostly local with inflammation and, much less frequently, necrosis at the injection points. by contrast, very few data are a

The significance of interferon and ribav

The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan

✍ Naoki Hiramatsu; Akinori Kasahara; Fumihiko Nakanishi; Takashi Toyama; Masahiko 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Changes in the Th1/Th2 ratio during a 24

Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Tomoko Fujimoto; Masahiko Tomimatsu; Daijiro Iga; Hitoshi Endo; Kuniaki Otsuka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Prediction of nonSVR to therapy with peg

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB